tiprankstipranks
JD Health International, Inc. (HK:6618)
:6618
Hong Kong Market

JD Health International, Inc. (6618) Ratios

22 Followers

JD Health International, Inc. Ratios

HK:6618's free cash flow for Q4 2025 was ¥0.24. For the 2025 fiscal year, HK:6618's free cash flow was decreased by ¥ and operating cash flow was ¥0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.72 2.72 3.77 3.28 3.45
Quick Ratio
2.39 2.39 3.39 2.93 3.08
Cash Ratio
1.53 1.53 1.46 1.03 1.14
Solvency Ratio
0.26 0.26 0.27 0.16 0.03
Operating Cash Flow Ratio
0.50 0.48 0.28 0.32 0.36
Short-Term Operating Cash Flow Coverage
49.87 48.06 0.00 0.00 0.00
Net Current Asset Value
¥ 34.85B¥ 34.85B¥ 42.43B¥ 32.93B¥ 39.95B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.01 0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.01 0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.36 1.36 1.29 1.30 1.37
Debt Service Coverage Ratio
16.28 15.29 82.40 250.90 -41.05
Interest Coverage Ratio
565.86 342.22 141.92 73.88 -15.95
Debt to Market Cap
<0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
0.20 0.20 0.08 0.07 0.07
Net Debt to EBITDA
-7.54 -7.85 -17.01 -5.06 303.92
Profitability Margins
Gross Profit Margin
24.78%24.78%22.88%22.17%21.16%
EBIT Margin
5.30%5.17%2.00%5.05%1.51%
EBITDA Margin
5.68%5.55%2.26%5.47%-0.13%
Operating Profit Margin
5.30%5.17%2.00%1.31%-0.31%
Pretax Profit Margin
8.21%8.21%8.25%5.03%1.49%
Net Profit Margin
7.32%7.32%7.16%4.00%0.81%
Continuous Operations Profit Margin
7.31%7.31%7.15%4.00%0.82%
Net Income Per EBT
89.16%89.14%86.77%79.52%54.63%
EBT Per EBIT
155.01%158.77%412.47%384.38%-479.47%
Return on Assets (ROA)
6.53%6.42%5.84%3.33%0.62%
Return on Equity (ROE)
9.03%8.71%7.54%4.34%0.85%
Return on Capital Employed (ROCE)
6.33%6.08%2.09%1.41%-0.32%
Return on Invested Capital (ROIC)
5.62%5.39%1.80%1.12%-0.18%
Return on Tangible Assets
6.69%6.57%6.02%3.45%0.64%
Earnings Yield
3.77%3.32%5.00%1.96%0.19%
Efficiency Ratios
Receivables Turnover
166.80 163.90 103.94 75.74 35.92
Payables Turnover
4.14 4.07 4.30 4.31 3.50
Inventory Turnover
7.98 7.84 7.68 8.19 6.14
Fixed Asset Turnover
59.16 58.13 72.39 185.87 185.53
Asset Turnover
0.89 0.88 0.82 0.83 0.76
Working Capital Turnover Ratio
1.97 1.82 1.53 1.46 1.20
Cash Conversion Cycle
-40.16 -40.87 -33.77 -35.27 -34.71
Days of Sales Outstanding
2.19 2.23 3.51 4.82 10.16
Days of Inventory Outstanding
45.73 46.54 47.55 44.54 59.40
Days of Payables Outstanding
88.08 89.64 84.82 84.63 104.28
Operating Cycle
47.92 48.76 51.06 49.36 69.56
Cash Flow Ratios
Operating Cash Flow Per Share
3.21 3.14 1.37 1.46 1.90
Free Cash Flow Per Share
1.93 0.00 1.36 1.44 1.89
CapEx Per Share
1.28 3.14 0.01 0.02 0.01
Free Cash Flow to Operating Cash Flow
0.60 0.00 0.99 0.98 0.99
Dividend Paid and CapEx Coverage Ratio
2.51 1.00 93.46 66.42 147.04
Capital Expenditure Coverage Ratio
2.51 1.00 93.46 66.42 147.04
Operating Cash Flow Coverage Ratio
16.20 15.62 16.77 21.44 29.61
Operating Cash Flow to Sales Ratio
0.14 0.14 0.07 0.09 0.13
Free Cash Flow Yield
4.40%0.00%5.15%4.16%3.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
26.54 30.12 19.99 50.90 514.97
Price-to-Sales (P/S) Ratio
1.94 2.20 1.43 2.04 4.19
Price-to-Book (P/B) Ratio
2.35 2.62 1.51 2.21 4.37
Price-to-Free Cash Flow (P/FCF) Ratio
22.73 0.00 19.41 24.04 33.37
Price-to-Operating Cash Flow Ratio
13.72 15.87 19.21 23.68 33.15
Price-to-Earnings Growth (PEG) Ratio
2.20 1.20 0.21 0.11 -3.83
Price-to-Fair Value
2.35 2.62 1.51 2.21 4.37
Enterprise Value Multiple
26.60 31.85 46.27 32.15 -2.91K
Enterprise Value
109.93B 126.53B 60.84B 94.20B 177.23B
EV to EBITDA
26.60 31.85 46.27 32.15 -2.91K
EV to Sales
1.51 1.77 1.05 1.76 3.79
EV to Free Cash Flow
17.71 0.00 14.19 20.77 30.22
EV to Operating Cash Flow
10.66 12.73 14.04 20.46 30.01
Tangible Book Value Per Share
18.73 19.00 16.86 14.98 13.68
Shareholders’ Equity Per Share
18.73 19.00 17.52 15.67 14.41
Tax and Other Ratios
Effective Tax Rate
0.11 0.11 0.13 0.20 0.45
Revenue Per Share
22.69 22.61 18.45 16.99 15.04
Net Income Per Share
1.66 1.66 1.32 0.68 0.12
Tax Burden
0.89 0.89 0.87 0.80 0.55
Interest Burden
1.55 1.59 4.12 1.00 0.99
Research & Development to Revenue
0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
0.17 0.17 0.08 0.04 0.05
Stock-Based Compensation to Revenue
<0.01 0.00 0.02 0.03 0.05
Income Quality
1.93 1.90 1.04 2.15 15.54
Currency in CNY